C-BHYJLife Length
telomere diagnostics, single-cell analytics, biomarkers
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-BHYJ
C-BHYJC-BHYJtelomere diagnostics, single-cell analytics, biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
This research project results from the interest in continuing the collaboration with the previous LL-HURS-ONC001 clinical validation study, which gives cause to the present study. LL-HURS-ONC001 was carried out with the participation of HURS' Principal Investigator and the team of experts in prostate cancer, as well as with the participation of the Sponsor's scientific and development team, Life Length SL, led by Dr. Najarro. The main objective of this study is to demonstrate the efficacy of the PROSTAV test in cutting down on unnecessary biopsies in prostate cancer screening/early diagnosis. PROSTAV is a minimally invasive test, easy to implement as biomarker for prostate cancer diagnosis. The efficacy of the PROSTAV test is clinically validated by the results obtained in a previous study, LL-HURS-ONC001. The purpose of this study is to advance in the development of new biomarkers in areas where there is a clinical need and where the telomeric profile influences medical decisions within the patient's clinical context. The association level between each individual's telomere biology and the results of the prostate biopsy will be confirmed. Data will be collected to subsequently delve deeper into and accurately establish the effect of this measure in prostate cancer patient management to substantiate its implementation in standard care.
Beyond Biotech podcast 5: ANeuroTech, ISA Pharmaceuticals, LifeLength Skip to content Search for: Suggested Topics: Categories Browse by resource or article category Knowledge hub Resources Biotech funding tracker Biotech deals tracker Biotech layoff tracker Biotech events 2026 List of biotech grants Biotech associations Categories News and Trends In-depth Best in Biotech Podcasts Top Pharma Strategy Opinion Expert Advice Sponsored Mending university and venture capital relations: is it possible to see eye-to-eye? Portugal: will the life science sector see upswing amid funding worries? Sectors … uroTech has just announced that after a successful pre-Investigational New Drug Application (IND) meeting, the US Food and Drug Administration (FDA) has given positive feedback on its pivotal phase 3b development program of ANT-01 as an adjunctive anti-depression drug for MDD. Cognitive function The ability to feel pleasure, used as a measure for the first time, and an improvement in cognitive function, have been included as a secondary endpoint in the phase 3b part of … t of the clinical trial. ANeuroTech will file for IND in the fourth quarter and apply for FDA Fast-Track Designation at the same time. More than 60% of people with depression and associated cognitive problems are not helped by initial treatments or experience challenging side-effects. ANeuroTech is developing ANT-01 as an adjunctive anti-depression drug with minimal or no side-effects. It is a low dose of an existing drug substance, pipamperone dihydrochloride, a typical anti
Conferences - Aptos View U.S. Products Your Message was sent successfuly Close Your Location Updated Successfully Close Add Procedure × Procedure Name Procedure Price (from) Procedure Price (to) Save About History What is Aptos FAQ Newsletter Activity News Conferences Articles For Patient Aptos with Hyaluronic Acid Aptos Intimate Products Trainers Rewards Log in Register for courses Distribution × Preparations Documents to be filled before the APTOS thread lifting What to know for before consultation to doctor Cost of Aptos thread procedure How to choose a doctor and a clinic for a … ology 25 October 2018 Aptos has been awarded the Pearl of Aesthetic Dermatology Award, presented annually by the SLDE, Polish Medical Association of Aesthetic Dermatology.I... Read more Aptos at ISAPS congress 25 October 2018 We are happy to announce our participation at 24th Biennial Global Congress 2018 being held in Miami organized by ISAPS. On November 1st room D-4 the... Read more Anti-age and Beauty Trophy 2018-19 24 September 2018 The Anti-Aging & Beauty Trophy is
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Clinique La Prairie – Longevity Med Summit Skip to content 21-22 April, 2027 Business Design Centre, London HOME ABOUT ABOUT THE SUMMIT VENUE AGENDA MEET 2026 SPEAKERS SUMMIT PROGRAMME 2026 2025 LMS CONFERENCES REPORT EXHIBITION TARGET AUDIENCE BECOME AN EXHIBITOR SPONSOR OPPORTUNITIES TAKE PART ABSTRACT SUBMISSIONS PRESS PRESS REGISTRATION LONGEVITY MED BLOG VENUE TICKETS CONTACT US HOME ABOUT ABOUT THE SUMMIT VENUE AGENDA MEET 2026 SPEAKERS SUMMIT PROGRAMME 2026 2025 LMS CONFERENCES REPORT EXHIBITION TARGET AUDIENCE BECOME AN EXHIBITOR SPONSOR OPPORTUNITIES TAKE PART ABSTRACT SUBMISSIO
CNIO and Merck sign license agreement for the development of new cancer drugs - CNIO ES EN Donate CNIO Friends News Events Research & Innovation CNIO Equality Education and career development Outreach About the CNIO Thanks to your donations Inheritance and legacies Tax deductions Our friends CNIO News CNIO Friends Newsletter CNIO Alumni Newsletter Scientific News Videos Galleries CNIO-CaixaResearch Foundation Frontiers Meetings Distinguished Seminar Seminars Women in Science Office Seminar Doctoral Thesis Philosophy and Science CNIO-Banco Sabadell Foundation Other Meetings Hotels Event Fa … y of the CNIO’s scientific and human resources programmes with the Severo Ochoa Award, accrediting CNIO as one of the eight Spanish Centres of Excellence in 2011. Maria Blasco has held the position of Director of the CNIO since June 2011. Since its creation, the CNIO has established collaborations with several national and international companies. Moreover, in the past three years, the CNIO has launched two spin?off companies: Life Length, focused on marketing in-house-develo
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Professionals - Advocates for Justice and Education Mailing List Signup 1200 G Street, NW Suite #650 Washington, D.C 20005 1-202- 678-8060 Toll Free: (888) 327-8060 Contact Us Events Donate Now! Home About Us Who We Are Website Accessibility Staff Partners Board of Directors Employment Programs Parent Training And Information Center Transition Advocacy Project (TAP) Legal Services – School Discipline Project Training and Workshops Parents Youth Professionals Request a Training/Workshop Archived Webinars Publications Our Impact Blog Quick Links Professionals Home / Professionals AJE List of Wor
%PDF-1.6 %���� 42 0 obj > endobj 68 0 obj >/Filter/FlateDecode/ID[ ]/Index[42 51]/Info 41 0 R/Length 125/Prev 192652/Root 43 0 R/Size 93/Type/XRef/W[1 3 1]>>stream h�bbd```b``� � �1D����'�Hy��"%��H�pi�D����L�g��k�j�A��Xd#Xv��]6 ,�= lf=�d �bkY���600]��6�&�30=x`9�w endstream endobj startxref 0 %%EOF 92 0 obj >stream h�b```" V�� � ce`a�������e�>`� �1�a��~��K �X�ϯ���4?�����{��oM��8yq����kߖ *�H5J�b�O����ٺ�J�ٛ{ ������[�FA����}� `WW@ �`�9X��5��� , �l�p#�Ly���˃2�3�3��p �gHR]��Ψ���7F��lA����&�Gz � �D Cڌ620�e00j; ~Ű�_)�w� �@@�O� endstream endob … 0(���Ey � ��-[ �jDZ�j�(b�j����a����z졭 endstream endobj 24 0 obj >stream application/pdf Jeffrey Morris Microsoft Word - AMMG Apr 2015 Conference Guide-V3.docx 2015-04-06T00:57:57Z Microsoft Word 2015-04-14T12:54:30-05:00 2015-04-14T12:54:30-05:00 Mac OS X 10.6.8 Quartz PDFContext uuid:2edd64d9-5bf2-9a4a-994f-70d49ce8151e uuid:9b9b6d90-cff6-e24a-8f12-bd9f75824025 endstream endobj 25 0 obj >stream h�26W0P0�P01V0�T040U01P0�0T���w�/�+Q����L)��1P)R��!������vvp���&&`
Life Length Telomere Test Available Nationwide Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Photos All Videos Multimedia Gallery Overview Trendi … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
Human Longevity - PMWC Precision Medicine World Conference Chat with us , powered by LiveChat Skip to content Chats Contact Speakers Agenda Tickets Menu FULL MENU FULL MENU Register here Rates by JUL. 2 Register here PMWC, Jan 25-27, 2023 PMWC - Silicon valley, ca January 27-29, 2027 Past Event PMWC, Feb 5-7, 2025 PMWC - Silicon valley, ca January 27-29, 2027 Attend Program Schedule Sessions Honorees Speakers Company Competition Showcases Travel Venue Sightseeing Reduced Rates Hotel Flights Exhibits + Map Login / My Account Participate REGISTER TO EXHIBIT Prospectus Attendee Breakdown Apply to … ogin / My Account Participate Register to Exhibit Prospectus Attendee Breakdown Apply to speak Sponsorship Inquiry GET UPDATES ABOUT Mission Testimonial Past Conferences Past Honorees Past Speakers FAQ CONTACT US Menu agenda speakers exhibits Contact us agenda speakers exhibits Contact us BUY TICKETS SAVE $1351 BY JUL. 2 Menu Item #1 Item #1 PMWC - Silicon valley, ca Jan. 27-29, 2027 Pittsburgh, pa sep. 23-24 PMWC - Silicon valley, ca Jan. 27-29, 2027 Register Here Rates by J … tend Program Speakers Travel Exhibits + Map Main Program View your save program Award Reception Speaker gallery Select part speakers Exhibit gallery Part conferences Participate Register to Exhibit Apply to speak Sponsorship Inquiry ABOUT Login / My Account CONTACT US Get Updates Pittsburgh, pa sep. 23-24 Register Here Rates by Attend Program Travel Reduced Rates Exhibits + Map Main Program View your save program Award Reception Paticipate Register to Exibit Apply to speak Sp … nomix Labs Alphaexpeditions Alpine Alquest Therapeutics ALS Emergency Treatment Fund Alta Bates Summit Comprehensive Cancer Center Alta Devices AltaQ Altered Egos Comics AltheaDx Althia Altiora Altis Biosystems, LLC Altoida Inc Altos Labs AltruBio Altum Medical Alum Alumot – sprint Aluna Health Alva10 Alveo Technologies Alverno Laboratories AlwaysRx Alykomed Global Solutions LLC Alykomedglobal Alzheimer’s X Alzheon AMA Ama-Assn Amaro Therapeutics Amazon Amber Health Amb … Y Ancestry Anderson Cancer Center Andreessen Horowitz Andrew Andy Strouse Angel Fund Angel Investor ANGLE Biosciences ANGLE Europe Ltd. ANGLE, plc Angleplc Angstrom Bio Angular Medicine Anima AnjaGen Consulting Anl Annai Systems, Inc Annexon Biosciences Annexon Inc Annexonbio Anocca Ansun Biopharma Antenna Anthem Anthony Pastena, M.D. ,P.C Anthos
BioAge partners with Age Labs to study healthy life length Skip to content Search for: Suggested Topics: Categories Browse by resource or article category Knowledge hub Resources Biotech funding tracker Biotech deals tracker Biotech layoff tracker Biotech events 2026 List of biotech grants Biotech associations Categories News and Trends In-depth Best in Biotech Podcasts Top Pharma Strategy Opinion Expert Advice Sponsored Mending university and venture capital relations: is it possible to see eye-to-eye? Portugal: will the life science sector see upswing amid funding worries? Sectors Browse by … than 100,000 northern European volunteers over more than 25 years of aging, and apply machine learning methods to the data to reveal molecular mechanisms of healthy human longevity. The agreement grants the company exclusive access for the purpose of drug discovery to data generated by the partnership. “Biobanks containing samples collected from healthy people over decades of follow-up are exceptionally rare, and can provide invaluable insight into the molecular bases of heal … benefit to both companies.” Expanding biobank partnerships Existing agreements grant BioAge access to other biobanks from multiple distinct geographical regions, collected from thousands of subjects with up to 45 years of follow-up after blood sampling. Biobank materials are coupled with health data including lifespan, disease status, and functional and cognitive outcomes. BioAge is seeking to expand the company’s human aging cohort data through additional biobank partnershi
Inflection Biosciences Licenses Preclinical Oncology Programs From the Spanish National Cancer Research Centre - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trend … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Inflection Biosciences Licenses Preclinical Oncology Programs From the Spanish National Cancer Research Centre June 3, 2013 | 4 min read Twitter LinkedIn Facebook Email Print Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Dublin, Ireland: June 3, 20 … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Eastern Biotech & Life Sciences, A Dubai Based Biotech Company, Introduces Telomere Test To The GCC Countries - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Tr … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Eastern Biotech & Life Sciences, A Dubai Based Biotech Company, Introduces Telomere Test To The GCC Countries September 8, 2016 | 4 min read Twitter LinkedIn Facebook Email Print DUBAI , UAE and MADRID , September 8, 2016 /PRNewswire/ -- Life Length, based in Madrid, Spain , the world leader in telomere testing appo … certain cancers. The field of telomere biology has grown dramatically since the award of the 2009 Nobel Prize for the discovery of telomerase. Clinicians today are increasingly becoming interested in incorporating telomere testing into their practices. This is largely driven by two factors: a growing understanding of the role telomeres play in personalized medicine; and increasing consumer demand for integrative treatment that can slow the aging process. Dr. Faruq Badiuddin , … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Download: Life lengths Successful journey with Tecan Service | Flyer | pdf | 402778 Loading Life length’s Successful journey with Tecan Service™
Oncology early diagnostics – Life Length Ir al contenido Longevity & PM HealthTAV® – Telomere testing for healthy aging & personalized care HealthOX – Oxidative stress testing for preventive and personalized care HealthNAD+ – Clinical NAD⁺ measurement for cellular energy & DNA repair HealthG – Saliva-based qPCR genotyping CRO/CRS LifeLengthTech® Platform Oncology early diagnostics About us About us Investor Portal Longevity & PM HealthTAV® – Telomere testing for healthy aging & personalized care HealthOX – Oxidative stress testing for preventive and personalized … n cells showing telomere signals (TAT®). * In 2023 we were distinguished with a grant from the Community of Madrid after obtaining the Seal of Excellence within the prestigious European Innovation Council Accelerator program, for research into the early diagnosis of lung cancer. Got any questions? Contact our team of experts Full Name Country of residence Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina
Life Length Analysis: Keep Health Partnership Subscribe | Contact Us Menu Key Health Factors 26 Key Health Factors for 2026 Your Personal Health Team Setting Your Health Baseline Setting Your Health Baseline: The Basics Biological Age Tests All of Us Arivale Function Health / Ezra Review Fountain Life: A Revolution in Preventative and Precision Healthcare Health.Keep Review Health Monitoring Devices Human Longevity’s Full Body Testing InsideTracker Review Life Length Measuring Your Biological Health: The Tests That Actually Matter PreNuvo Review Radence Review Viome Whole Genome Sequencing Sle … eat results. Why are medians important? A bell-shaped curve of results does not apply to telomeres. For telomere dynamics, a spike to the left of a bell-shaped center would be a healthy normal. The median correlates with that spike on the left. Telomere average is the center of the bell-curve and thus longer and giving misleading results that their customers are younger. Thus, median telomere length is far more important as an accurate health biomarker. This concludes today&# … Next Viome 0 12851 Share: How useful was this post? Click on a star to rate it! Submit Rating Average rating 5 / 5. Vote count: 3 No votes so far! Be the first to rate this post. Leave a Reply Cancel reply Your email address will not be published. Required fields are marked * Name * Email * Website Δ Please Login to leave a comment or a reply [ihc-login-form] [miniorange_social_login] MENU MENU Key Health Factors 26 Key Health Factors for 2026 Your Personal Health Team S
%PDF-1.7 %���� 216 0 obj > endobj 229 0 obj >/Filter/FlateDecode/ID[ ]/Index[216 24]/Info 215 0 R/Length 73/Prev 17657353/Root 217 0 R/Size 240/Type/XRef/W[1 2 1]>>stream h�bbd``b`�$��c�`�,�@: ��Dlq?�dA�: �0����! d#1�F� � endstream endobj startxref 0 %%EOF 239 0 obj >stream h�b```f``2c`a`R}� " �@Q�`Y�й�n��P�t �߫�x������j��� 'x]�� -�I�n-^�"5����9W�f/y�o�h�����,O �����{78s�.*Z��}@��yA�� � \ [�5l`�c=�S�x������B"�|� Q��1GA�au�XF�\#�(�u�[d� endstream endobj 217 0 obj > endobj 218 0 obj >/ProcSet[/PDF/Text/ImageC]/XObject >>>/Rotate 0/Type/Page>> en … 4-05:00 2017-01-06T14:57:24-05:00 Adobe Acrobat Pro DC 15 Paper Capture Plug-in application/pdf uuid:df841ae2-c4d7-4e60-b847-6b037e4899b3 uuid:dd45f221-3905-41d7-9a71-6225c648a88d endstream endobj 92 0 obj >stream hޔ�� 1�_e� �n~����;�80���w���L�T�X�,;3_�h��Ɛ�"LFRQ)�X��������$Zm/���k�UT��E�j��g5�� �X�Q ��p�#�{��gX+6 ��Ѩ��8��M'��+�L˳�����s�s�J�J�J�ʠ!H H H�H��?�`0mt6 endstream endobj 93 0 obj >stream h�\ͱ � ��W�-q��J] ��L >/Filter/FlateDecode/ID[ ]/Info 215 0 R
SAJP South African Journal of Physiotherapy 0379-6175 2410-8219 AOSIS SAJP-79-1939 10.4102/sajp.v79i1.1939 Review Article A scoping review of prehabilitation interventions for arthroplasty patients https://orcid.org/0000-0002-9546-3854 Pillay-Jayaraman Prithi 1 2 3 https://orcid.org/0000-0003-2934-8687 Chetty Verusia 2 https://orcid.org/0000-0003-2306-7681 Maddocks Stacy 2 1 Chris Hani Baragwanath Academic Hospital, Faculty of Health, Gauteng Department of Health, Johannesburg, South Africa 2 Department of Physiotherapy, Faculty of Health Sciences, University of KwaZulu-Natal, Durban, South Af
Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders Cochrane Database Syst Rev . 2018 May 14;5(5):CD012342. doi: 10.1002/14651858.CD012342.pub2. Authors Reem Malouf 1 , Asma Ashraf , Andreas V Hadjinicolaou , Carolyn Doree , Sally Hopewell , Lise J Estcourt Affiliation 1 National Perinatal Epidemiology Unit (NPEU)
Heliogen, Inc. (Form: 10-K, Received: 03/31/2022 17:19:25) 00018402922021FYFALSE0.332http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent2510http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent00018402922021-01-012021-12-310001840292us-gaap:CommonStockMember2021-01-012021-12-310001840292us-gaap:WarrantMember2021-01-012021-12-3100018402922021-06-30iso4217:USD00018402922022-03-25xbrli:shares00018402922021-12-3100018402922020-12-31iso4217:USDxbrli:shares000184029 … eding 12 months (or for such shorter period that the registrant was required to submit and post such files).Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated fi … rs to rely on a combination of their balance sheets and project-finance debt to fund construction costs. If our customers are unable to raise funds on acceptable terms when needed, we may be unable to secure customer contracts, the size of contracts we do obtain may be smaller or we could be required to delay the development and construction of projects, reduce the scope of those projects or otherwise restrict our operations. Any inability by our customers to raise the funds … d head of SEC Reporting, who have the requisite background and knowledge in the application of GAAP and SEC rules and regulations. • We engaged external experts to complement internal resources and to provide support related to more complex applications of GAAP, tax and internal controls. We will continue to utilize outside resources, as necessary, to supplement our internal team. • We began the implementation of a new company-wide enterprise resource planning sys … ming and costly. Those laws, regulations and rules and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws, regulations and rules, as interpreted and applied, could
Infinite Epigenetics Acquires Tally Health to Expand Persona · Discoperi M&A Intelligence Home / Deals / Infinite Epigenetics / Tally Health Verified Healthcare Acquisition 29 Apr 2026 Infinite Epigenetics acquires Tally Health Infinite Epigenetics → Tally Health · Healthcare · Acquisition Close date 29 Apr 2026 Announced 29 Apr 2026 Deal value Undisclosed Quality score 91% Acquirer HQ 🇺🇸 Target HQ 🇺🇸 AI-generated analysis Infinite Epigenetics' acquisition of Tally Health bolsters its position as a leader in epigenetic diagnostics and personalized health interventions by integratin … ate plausibility 1.00 Value plausibility 0.60 Entity quality 1.00 See an error? Submit a correction → · All corrections reviewed within 24 hours. Key facts Sector Healthcare Deal type Acquisition Value Undisclosed Close date 29 Apr 2026 Announced 29 Apr 2026 Quality score 91% Acquirer HQ 🇺🇸 Target HQ 🇺🇸 ☆ Save deal Export this deal ↓ Export JSON ↓ Export CSV Related deals
Elizabeth Henske, MD    HOME    RESEARCH    CONFERENCE    GUIDELINES    JOURNALS    STORE   LOGIN   DONATE   JOIN   RENEW   CME/MOC   SEARCH   MENU " id="mega-menu-about" a href="/about/">ABOUT Overview Annual Report Governance Bylaws Leadership Board of Directors Nomination Process Organizational Structure ATS Policies ATS Website MyATS Tutorial Newsroom ATS Experts Press Releases Member Newsletters ATS in the News ATS Conference News Embargo Policy ATS Awards ATS Social Media ATS … ter Community Respiratory Medicine Book Series ATS Fellow Elizabeth A. Rich, MD Award Member Directory ATS Career Center Welcome Trainees ATS Wellness Member Newsletters Chapters Thoracic Society Chapters Council of Chapter Representatives Chapter Publications CME Sponsorship Corporate Membership SITEMAP Awards Home ▶ Patients ▶ Public Advisory Roundtable ▶ Awards ▶ Elizabeth Henske, MD submenu Public Advisory Roundtable PAR at the ATS International Conference Awards PAR Memb
Front. Psychiatry Frontiers in Psychiatry Front. Psychiatry 1664-0640 Frontiers Research Foundation 10.3389/fpsyt.2010.00127 Psychiatry Review Article Age-Dependent Branching Processes for Surveillance of Vaccine-Preventable Diseases with Incubation Period Slavtchova-Bojkova Maroussia N. 1 2 * González Miguel 3 Martìnez Rodrigo 3 1 Faculty of Mathematics and Informatics, Sofia University Sofia, Bulgaria 2 Institute of Mathematics and Informatics, Bulgarian Academy of Sciences Sofia, Bulgaria 3 Department of Mathematics, University of Extremadura Badajoz, Spain Edited by … ndividual), respectively (see for example Daley and Gani, 1999 ; Farrington and Grant, 1999 ; Mode and Sleemam, 2000 ; Farrington et al., 2003 ). Intuitively, λ represents the power of the virus and u the length of the incubation period. Hence, the average number of infected individuals by one infected individual is considered proportional to its incubation period, i.e., the larger incubation period is, the larger will be the number of infected individuals. With respe … 00F3;n Cientìfica, Desarrollo e Innovación Tecnológica, grant MTM2009-13248 and by appropriated state funds for research allocated to Sofia University (contract No 112/2010), Bulgaria. References Andersson H. Britton T. ( 2000 ). Stochastic Epidemic Models and Their Statistical Analysis. Lecture Notes in Statistics , Vol. 151 . New York, NY : Springer-Verlag . Ball F. Donnelly P. ( 1995 ). Strong approximations for epidemic models . Stoch. Process. App … cs 4 , 279 – 295 . 10.1093/biostatistics/4.2.279 12925522 Farrington C. Grant A. ( 1999 ). The distribution of time to extinction in subcritical branching processes: applications to outbreaks of infectious disease . J. Appl. Probab. 36 , 771 – 779 . 10.1239/jap/1032374633 González M. Martìnez R. Slavtchova-Bojkova M. ( 2009 ). Age-dependent branching process as models of infectious diseases . C. R. Acad. Bulg. Sci. 62 , 541 – 550 . Gonz … erties of the extinction time of Bellman–Harris branching processes: an application to epidemic modelling . J. Appl. Probab. 47 , 58 – 71 . 10.1239/jap/1269610816 Isham V. ( 2005 ). “Stochastic models for epidemics (Chapter 1),” in Celebrating Statistics Papers in Honour of Sir David Cox on His 80th Birthday , eds
LifeLengthTech® – Telomere & Cell Biology Platform – Life Length Ir al contenido Longevity & PM HealthTAV® – Telomere testing for healthy aging & personalized care HealthOX – Oxidative stress testing for preventive and personalized care HealthNAD+ – Clinical NAD⁺ measurement for cellular energy & DNA repair HealthG – Saliva-based qPCR genotyping CRO/CRS LifeLengthTech® Platform Oncology early diagnostics About us About us Investor Portal Longevity & PM HealthTAV® – Telomere testing for healthy aging & personalized care HealthOX – Oxidative stress testing for … ntegrable with TAT ® for targeted profiling. LifeLengthTech ® Directory Find by application, sample type, technique or target Filters Application ALT research Antioxidant potential Biological aging Cells subpopulation selection Cosmetics DNA repair Drug screening Immunology Induction Metabolic fitness Mitochondrial assessment Nutraceutical Oncology Oxidative stress Photoprotection Protection Repair Selection of expression in cells Senolytics Senomorphics Telomerase activity a … ion of > 220 TAVs (Telomere Associated Variables). q-FISH (confocal/imaging) Application Biological aging , Cosmetics , Drug screening , Nutraceutical , Oncology , Telomere length assessment Sample type Cell culture , Cell lines (non-tumor) , Cell lines (tumor) , PBMCs , Tissue/biopsy More info Life Length patented Telomere Analysis Technology (TAT®) is based on a quantitative fluorescence in-situ hybridization (Q-FISH) method modified for cells in interphase. In brief, te … RS Robust quantitative RT-PCR assay for assessing the expression of hTERT. qPCR Application Drug screening , Oncology , Telomerase expression , Telomerase regulation Sample type Blood , Cell lines (non-tumor) , Cell lines (tumor) More info Using a custom TaqMan® real-time quantitative PCR assay to assess mRNA hTERT (the gene encoding the catalytic subunit of telomerase), this method enables sensitive and reproducible detection of telomerase gene activation. Highlights of the … tion with our Telomere Analysis Technology. q-FISH (confocal/imaging) , RNA-ISH Application Cells subpopulation selection , Selection of expression in cells Sample type Cell culture , Cell lines (non-tumor) , Cell lines (tumor) , Tissue/biopsy More info RNA expression detection in spatial context, in combination with telomere length analysis in s
Bovine Colostrum, Telomeres, and Skin Aging - JDDonline - Journal of Drugs in Dermatology &noscript=1" /> &noscript=1" /> Close Search Home Issues Current Issue eJDD Featured Articles Archived Issues Supplement Library Case Reports Unlocked Access JDD Corner Clinical Solutions Topics Atopic Dermatitis Oats in Skincare Oncoderm Pigmentary Disorders Psoriasis Inclusive Dermatology Atlas Social and Technology Latest News CME CME Activities Multimedia JDD Corner Video Abstracts Podcast Webinars Translational Lecture Series Video Pearls Info About JDD Advertisers Media Kit Podcast Sponsorship Repri … dia Kit Podcast Sponsorship Reprints Contact Us Authors Instructions to Authors Submit a Manuscript Author and Peer Review Login Editorial Board Events Contact Editorial Why Publish in the JDD? Institutional, Library, & Corporate Subscriptions Reprints Contact Us SanovaWorks Inclusive Derm Atlas Online Gallery Digital Edition Subscribe Now Log In x-twitter facebook linkedin instagram Bovine Colostrum, Telomeres, and Skin Aging May 2021 | Volume 20 | Issue 5 | Original Ar … dia Kit Podcast Sponsorship Reprints Contact Us Authors Instructions to Authors Submit a Manuscript Author and Peer Review Login Editorial Board Events Contact Editorial Why Publish in the JDD? Institutional, Library, & Corporate Subscriptions Reprints Contact Us SanovaWorks Inclusive Derm Atlas Online Gallery Digital Edition Subscribe Now Log In Search Search x-twitter facebook linkedin instagram
BOOK BUDDY - Ibn e sina always preferred valuing the... Facebook Log In BOOK BUDDY's Post BOOK BUDDY April 22 · Shared with Public Ibn e sina always preferred valuing the quality of life over the quantity of years. A short life with width suggests a life that is rich in experiences, courage, passion, and meaningful moments. It’s about taking risks, exploring opportunities, building relationships, and truly living rather than just existing. On the other hand, a narrow life with length refers to a long but limited life, one that may be safe and routine, but lacks depth, excitement, or fulfi
%PDF-1.7 %���� 406 0 obj > endobj xref 406 34 0000000016 00000 n 0000002359 00000 n 0000002490 00000 n 0000003012 00000 n 0000003685 00000 n 0000004320 00000 n 0000004407 00000 n 0000004521 00000 n 0000004558 00000 n 0000005220 00000 n 0000006142 00000 n 0000006687 00000 n 0000006962 00000 n 0000007550 00000 n 0000007664 00000 n 0000007748 00000 n 0000008305 00000 n 0000008851 00000 n 0000009485 00000 n 0000039661 00000 n 0000042310 00000 n 0000047808 00000 n 0000059405 00000 n 0000064754 00000 n 0000065706 00000 n 0000066429 00000 n 0000066468 00000 n 0000116101 00000 n 0000182076 00000 n 000 … z>d�*�H ��* � [�SM�Maz�����u�qqy,�( �=���l/����dY �LĨ���m�C �F��@c� $��n^RFp��Qd�$٨xU.���=��Zд̛��w�q>v��s�?4��[-:iOb� ?μΦ��~j�P�L���I� �]2_w&����I ���.�Nr�����.E��T �1[���@�+����E)�lTu=V�v���%�6iӕ�i��jh��R� ��gsTլl�� >��uS�6�\� yd �3�Ef��R�wqO� W��Y���cͿ��RQ�.�w/�46Ѭv�,AF7s�Շ�%���[��p��2�qު\4��-�����(�^��5c�1]4��[y>�O��o�K$����� 2ೝBR�Tź�� e�`�{֪�b&�,���H�ۿ/Mh�l4���V̻6�>�s�/z� ��|��������ҝ����8�܈ ���Y��k�0��Ta��ggUIǥV����;�# E�.� … 41-21584e0bcc14 xmp.did:BDA62478DE79E311A118E8D61D5F8570 default converted from application/x-indesign to application/pdf Adobe InDesign CC 2015 (Macintosh) / 2016-07-27T10:36:36-05:00 application/pdf Adobe PDF Library 15.0 False Gesta 2.010 0 0 -- OpenType - PS 250895214 Gesta-Regular 250895214 Gesta 2.010 0 0 -- OpenType - PS 3215785910 Gesta-Italic 3215785910 Gesta 2.010 0 0 -- OpenType - PS 13887036 Gesta-Bold 13887036 Open Sans 1.10 0 0 -- OpenType - TT 3800405862 OpenSa
%PDF-1.4 %���� 521 0 obj > endobj xref 521 46 0000000016 00000 n 0000003136 00000 n 0000003371 00000 n 0000003415 00000 n 0000003550 00000 n 0000003586 00000 n 0000003676 00000 n 0000004053 00000 n 0000004197 00000 n 0000004340 00000 n 0000004382 00000 n 0000004689 00000 n 0000005063 00000 n 0000005105 00000 n 0000005699 00000 n 0000006214 00000 n 0000006353 00000 n 0000006754 00000 n 0000007238 00000 n 0000007752 00000 n 0000008226 00000 n 0000008759 00000 n 0000008788 00000 n 0000009205 00000 n 0000009373 00000 n 0000009546 00000 n 0000009616 00000 n 0000009856 00000 n 0000009939 00000 n 000 … dobj 513 0 obj > endobj 514 0 obj > endobj 515 0 obj > endobj 516 0 obj >stream application/pdf anonymous 2025 ESS Tech Inc Form 10-K Filing-2026-03-05-13-18 2026-03-05T21:18:57Z Workiva 2026-04-15T16:04:50-04:00 2026-04-15T16:04:50-04:00 Wdesk Fidelity Content Translations Version 014.009.078 uuid:899bbdd3-ff55-4fd3-9c9e-a0a23ef56c72 uuid:6c52c096-9d3f-413d-82d0-6f3e0ab3af92 endstream endobj 517 0 obj [518 0 R] endobj 518 0 obj > endobj 519 0 obj >stream H�b``������$��PPTR�
Calico, Google's biotech company, joins the Longevity World Forum - Longevity World Forum The congress About Madrid Speakers Speakers 2026 Previous Speakers Media News Gallery Videos Sponsorship EN ES Menu The congress About Madrid Speakers Speakers 2026 Previous Speakers Media News Gallery Videos Sponsorship EN ES The congress About Madrid Speakers Speakers 2026 Previous Speakers Media News Gallery Videos Sponsorship EN ES Menu The congress About Madrid Speakers Speakers 2026 Previous Speakers Media News Gallery Videos Sponsorship EN ES Tickets Instagram Facebook-f Linkedin Youtube Calic
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
Health insurance should do more... - Tampa General Hospital Facebook Log In Tampa General Hospital's Post Tampa General Hospital Verified account June 9 at 12:09 PM · Shared with Public Health insurance should do more than cover costs—it should help you live better. In this episode of our #GiveItToMeStraightDoc podcast, we explore how value for your health insurance dollar is changing and why it matters to patients. #WeAreTGH #HealthcarePodcast Listen to the episode on major podcast platforms, or watch the full video on YouTube here: https://bit.ly/4nCjqu5 YOUTUBE.COM Insurance: The Truth
%PDF-1.6 %���� 3333 0 obj > endobj 3347 0 obj >/Filter/FlateDecode/ID[ ]/Index[3333 153]/Info 3332 0 R/Length 99/Prev 27335913/Root 3334 0 R/Size 3486/Type/XRef/W[1 3 1]>>stream h�bbd```b`�d� �@$�oɴ LN��� ��,XM0�T�˂T2��b'ŁH�@�ߤ$&F^�^�y�'�?���Qr$��s� ���0q-v endstream endobj startxref 0 %%EOF 3485 0 obj >stream h��Z{\W�?3�LBH!�� OA��(�8 ����D!"�����8���ҖZ[����ދֶ���gPDڏ]�EEkm���^�k]n���3� $������hr������=�� ����B�{� GJ�B ��C�-��+��~�H-Z f��#)i)0Yxr*���q��J�BnX���`#.!�]Atf�l*фU��7��e F�ɧ�Y*�>�-lPy\.��F��n��j�mP�ğn ��hQvЩ4r?��8UA�XMH`�PDŗ��K ��;��yt�:E�d�zj� … #�4�Aգ rO��]�Ǖ�Jl�o4����2i�ZH p�Ri;$���AI��3�P� w7�Z� 2�g�Ŏm���� F0 5)��RFp}�Ѧ> ��}ĉ���k�p�t�A�#NN�*��� ���7�Y�u���p�(����� o�I��t�n�*����Br��7��WA/� ��!�FiRzc�����B-MJ��Xij�nC�`-O %�h���pԎ�q��a��k�FK}A Ŵ�Fl�.,�����(���v {[�?��Y�`��� |��Dx���r�3]�vf� ��ٚ)�M�2t�Kn�UV{F�L6mɌ|R�D�M4�v��͵#M@�w��Ӑ����Op�$ǥO�z*$�^�@���?�L)���� 4�Q��j�b�$Su%^͘��S��҄��%���9���X!�f "� �s �J� Y��lE��*���Ɋ��J��!�M�)\�2����N[�x7��ț����f�@ʍ�L��vd��X���ߎ� … }p� ���K�� 2 ���-X[+�6� ��i�K`�U�^ )��"�;{�y!Ն�*kmK�r0�V��ɉ���~���қrFpo�j�xNܑ�Ru��~��:sn�%�mrԚ��� �P��#��!� ]&`|�]��2� �� ���7�rn�B�s���7,>@v� 3��v%$��s�����P�I�bVǩc�h�R��� cذp@����Z�ϻ��1dt�e�m#R�KPà˯#�Vr��H�I��z��� �$z�=��$�+�ِ���P#�~y�"X�[Hk`�#���*��8�-!p��ǟ��.a)���~%֮��݁h�1ϧ֫��-RB �d�'&��a��"]Fs� 1*�Z��7 �&���DʍHu@���,["���8XX�? ����nU�w �k �� +� $�f���u��-^���`�=G������h�8� ̚t�ñ��V ����p���-��jIo��:��G 3�i��\i��)㒤 ֹ�N�횩C�!�w��}� … #�'�ڽXƕ 2����p�� ��-5,�}un�f1�݆!�C\���]��_ʂ �$M)*C2������}_�F������pt֑b�RfP���o�^��/ i�ρ�4۫F2��v����^r9&� \�j{�������^(�o�?0������ !�;�ȯP��j7��=�.�;��G-�c���T�>� WL��~Y ʎGO�/]��m�V���0�����4����B�=����u�Z ���g��!����%��њ�b1(����`}���"x&�X�,����C!f!�`I.ǷN�� ���������Iv���R$�0p;�e/�,5k(��f�_-U��To^�z�Ex�g57 ���S�> h0A�F����xW���/(ǯ�5�����:���� IUn!b��n6�r>��|)��-%�w�̓v�����{�yg���F�4��h�n07�R�����b� z�E�SѼ;�}3��U�[��@��ې��z|��k��x������l�@{ … �� ���Ζ5�2���˭�����֑�KD _�oJ[�m�UK1��t�9� ؇@��F���ɒ����Y���0 ��2g�ʊ��58b�N��rFp'S�:T]I���&� #ʂ:�s�d��s �8�sF�̧|Nq���̶�ޅ=��� ����4�JO�� ��ʩ�h��G6�0�V�#G�@��ӛ?_�S���!�,\鬑����T|�����=����/z�]r9����iE�j:'�}����C+y|�z _14��mi� �k�uvL�XB���c�"4�� ��- �УM �/���T#P1� o �qH���v���č��B���B\ b��6�#P����X�nd���"f*��1�Ӽ{��*Ir9X�1�
%PDF-1.4 %���� 312 0 obj > endobj 320 0 obj >/Filter/FlateDecode/ID[ ]/Index[312 51]/Info 311 0 R/Length 66/Prev 302482/Root 313 0 R/Size 363/Type/XRef/W[1 2 1]>>stream h�bbd``b`��@��b~$�^ �6 Q�H�c`bd >stream h�b```f``*e`2�30 �P�9:��r�5� ���I8�ǒ���g� �?�v��Z���yfs[q���}�˒ۃm#�c [���\��s6s6�O��Ξ�ŭ�����{;��� �4@�e��d endstream endobj 313 0 obj > endobj 314 0 obj > endobj 315 0 obj >stream hޤ�[k�0��� 7X��-نHҦ l]��ZyP -��%�*k��Α#� �Q���H�N � }}�a2�^�В�]�x����l�[��볆�tB��54�B�G&��mo���ǐ3i3SY'�����ɷ;K�T��t����� �mI����u5�p��ED0�gB�]t�˼x{��KӒ;� �դj�ޞ�Mkg;��˜����w��)\r� … ����w�ڮ����m�iek8���(��U�Y>��n��������l*�]��-e ��� ��]�mt�~�5t�ӵ�w >stream application/pdf Report of the Sponsorship Group on Measuring Progress, Report of the Sponsorship Group on Measuring Progress, everapi PDF CoDe 2012.3410 (c) 2002-2011 European Commission 2012-02-01T19:56:30+01:00 2012-03-02T14:18:55+01:00 2012-03-02T14:18:55+01:00 uuid:30117cfd-4a8c-422f-88d6-948ecd8307c0 uuid:9d9e7d94-8c46-44a9-9fef-59b5308fed0a endstream endobj 145 0 obj >stream hޜ�1k1 �]bɶd
%PDF-1.7 %���� 1648 0 obj > endobj 1658 0 obj >/Filter/FlateDecode/ID[ ]/Index[1648 20]/Info 1647 0 R/Length 67/Prev 5819319/Root 1649 0 R/Size 1668/Type/XRef/W[1 2 1]>>stream h�bbd``b`{$� fGq D� �k@B�HpE��{@"� #� ������w�O�4� endstream endobj startxref 0 %%EOF 1667 0 obj >stream h��U�Oe�z���v�GW�Į_X�� �1.�b�2 - 2h�еB27�K\�n;b��/s2�i�0]\���]�P���|5�D ���ę!��L��5ҍ�^r��� $�z�zȪ��o�S�Y:�_T"��R{]� �D���J:����w����B ���m�b*�p������A"j�Uf��*�5DF��A �3��VέF��CU(�o� UI�Y�2н�윫�E�'�LW�7?�h\�r1�a�:���p8 mLj�(��"D�,!������� gI�b I�\F�`�#&o3Y��P��N�[�rD��c� �$$��>)B … ��q�sU�� �'������r9Թ?�l�H�J��w�:=I��q��+ ��sNF��j&�|"S[���w�[�/2 �>vv��U rFp&�d�ʌ�J�}Ju�� �O�M�u�,t�蒅ϻʹ�|L?��%{��| +�;�6= 'R��'# X���j�b[������ʑ(�cP����m ��Q� Rj� #�'�w���yb�(@q\j��9��tS�ωU𥽏�0��sf����5`�r�e;�\��#���Č��]�t��e�~G��jx�b�\�TA�K�,�ʢ��2 ��[�W���` ��4�U,�嗦y��&��B�d���ĕM��QA�vO)�f��?�U�#�n�R���>C�Qm���ǒ����oc�iE�"��DF���s�n�1m�r���VW(Ɏe�I� ��b���o�v.�.Q������?(�7Gչ9 ԉS�w hx% Eؾ�!��@���@C�PȔa�i)s0� �2����+�hV���~ … f75c254ef xmp.did:2f63ebd5-06a0-412c-b160-78a9e34d6b8f proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign 15.0 (Macintosh) / 2020-04-09T12:36:58+03:00 saved xmp.iid:2f63ebd5-06a0-412c-b160-78a9e34d6b8f 2020-04-21T14:26:05+03:00 Adobe Illustrator 24.1 (Macintosh) / uuid:d384fc99-bba1-a043-9f20-39a2f05e4a8c xmp.id:ba042be6-51e8-4c51-a3d3-126f060d1bf9 xmp.did:4f3cd92f-a7c0-4d84-a9de-d27f75c254ef proof:pdf application/pdf Climeon_2019_organisation_c … ۷�eO]�ìUG�� ��#��ᑗ������t�����Cr�[� 0 s�� endstream endobj 118 0 obj >stream application/pdf Climeon_2019_styrelsklockan Adobe Illustrator CC 23.0 (Macintosh) 2020-04-19T22:52:07+03:00 2020-04-19T22:52:07+03:00 2020-04-19T22:52:07+03:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:899f7184-e495-4f6c-b390-58e421608991 uuid:445c4f79-bc7d-2e4a-9636-ee4a534efca6 uuid:ebee2ec7-c25f-954b-8805-4dbf4c5d4d00 xmp.did:902e7148-0c1a-477c-a69e-7e0412ec42ad uuid:65E6390686CF1 … ��c} W�Ʌ4UӤ�os1'�^�ZN�M1K p0�E��x��͍Z��t��x���gΜ%c�Jg��vP�>�Ei� h >stream application/postscript Web Amy Unsworth Adobe Illustrator CC 22.1 (Macintosh) 2018-07-03T11:50:19+02:00 2018-07-03T11:50:19+02:00 2018-07-03T11:50:19+02:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:54a565c6-9810-41e6-b1fe-d22ee14d164e xmp.iid:54a565c6-98
%PDF-1.5 %���� 1 0 obj >/ExtGState >/Font >/ProcSet[/PDF/Text]/XObject >>>/Rotate 0/TrimBox[0 0 623.622 793.701]/Type/Page>> endobj 2 0 obj > stream xڝYYs�8~W�� �-��-�iʱ���l�ki3����`�0�� �������C�f��T"h��ȏ��+S��j���.>�]�,.Y�^|ܸ�Z �9��\\�B*���8SBdZ��~�����,V�q��,R���Y��uB/ #��$� ��D@ ��s3�}�q�8_�������#��|�0���G���_���n���&�/~� ��FC����=H�����ܑ��#�i�w�J��V� �=䕁|�/���uyK o >?�Ƒ�����#��O��h�9K�9��C�?�=u��O���CN�"KH;q�'$�gM}}63��ƾ� kF�-3"V$�%K+QJ� V����@�1��a/d����!�5��p9"��Z�r����H�|�|ޒ ��܁�#/eE%E��Lc�!p�N� �Ocx%6[Z��-���e�U�i� ��EEΕ������$�kK����� … �i$�� �A��(s�2�q�--?��C�M(g�4|y�M�n�� �� q{��`�cly�j��P�� ��ʓb=�)�c��Rfp��~�����{�z*�v�3G��tb�� ��2"���������v�v�!� b ��\e�[����)�V��k�&|����v��:�S�7/��ފ�YXr�W kjB�d�Bϓ�Yq����څ;����żŨ6��4��D�u�Ѝ���0�k潼p=�1.*� I+d#�o�!�:�.�BJ|�� �n�(N�&���� f�U���� �a4��-���ȿ�S�pl���OᇂG���� ���1���ѯ9 �'�F�A-�Rk�]���/%��GU{�iN�����K,��������=�gz� ����Y�ƻ��� �� ����ͽ�)�ע�k��Qǣ��F��"�b����^|^A���`[yZ�0Xs!xk��*r�������M��Q��y��'�/����G�jJ��L�ff6�ي�
%PDF-1.5 %���� 4708 0 obj > endobj xref 4708 74 0000000016 00000 n 0000014250 00000 n 0000014367 00000 n 0000015693 00000 n 0000016363 00000 n 0000016659 00000 n 0000016956 00000 n 0000017629 00000 n 0000017896 00000 n 0000017935 00000 n 0000018114 00000 n 0000018292 00000 n 0000018470 00000 n 0000018731 00000 n 0000018846 00000 n 0000019110 00000 n 0000019225 00000 n 0000023860 00000 n 0000024113 00000 n 0000024292 00000 n 0000024409 00000 n 0000024720 00000 n 0000024749 00000 n 0000028974 00000 n 0000029152 00000 n 0000029330 00000 n 0000033476 00000 n 0000037139 00000 n 0000040661 00000 n 0 … V�Z���=4����wi�\#�2�C"������3�BukSV�g��r����C�KJ:f�� [N��� T�9v���@ P����rFp�:�Y�*ղ�/��;~��ⶒ�՝&`�Iw�\�V$ E 2�L��M� �;�z�:��`�KM8�w��)j�o��A�筮1IWUE L�Z(�Hs ]E3�d���|��>�P�f=QI��[�t�t?S��:{���5�UGz����4Td �*ef��Yk ����éy\��4�� | �:�ġ�Ό���z>��CG T�,ST,����ۘ� ��6��d�q �:]CRד�8��$�� �OGh��ۖ���^�QJa�)�4�K,�CH�aH\�6���/%��V��N�$�4���g�CUUӯ{4��G ,EBV�����"��� z��i�x��s4�2�\�\d�ϐO���y;Uϑ}��G�ޤ��25Lp�4R�Ք�#%�[�8b�X��`�_}S9% ����鞒�ACl~�آ������XK��*$ … �z����F+}{Qk˲翂:=F+�"��{q�ƙ7�r�"aI� ǒ0��˟��_����'=[����N���> x��nD�� � ��rFp' ��q��(�\�@��������� >��Wہ� X���W���x Z �И���>\{�������5��m���|`������� ������������?��?��� N�D�G8���s�����?��'#�� ܁����� �?��g'�~����{� ́�+�?�����P @(��P @(��P @(��P @(��P @(��P @(��P @(��P @(�; 'V��/��=2�k+�)�������� �`���C#���AR@L �K���ֲ�ϩ A�-��s��Z�ɴw�� h֮�Ȑ[��H� 1�%LJ��� � %}��Է:gU��4�wޟ���+[�5�B� �� [��6k�L��\��� |L g�p1���8� … dobj 225 0 obj > endobj 226 0 obj > endobj 227 0 obj > endobj 228 0 obj >stream application/pdf LB 2025_ Land Bank Organisational Overview 2025-08-27T14:30:40+02:00 2025-08-27T14:30:40+02:00 2025-08-27T14:30:40+02:00 Adobe Illustrator 26.3 (Macintosh) uuid:54fff600-1d62-d848-82af-35c398384ce2 xmp.did:99086174-e7d0-49ea-9d3c-555df9f58634 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:76b108ec-dcfe-4d12-8a05-9b34b1fd2c86 xmp.did:5cace282-7b96-2943-a43d-1dd8c9914347 uuid:5 … 0 Adobe PDF library 16.07 endstream endobj 229 0 obj > endobj 230 0 obj >stream application/pdf LB 2025_ Land Bank’s Footprint 2025-08-24T14:40:10+02:00 2025-08-24T14:40:10+02:00 2025-08-24T14:40:10+02:00 Adobe Illustrator 26.3 (Macintosh) uuid:02437fc8-0837-3d44-8608-f5c8c051daee xmp.did:99086174-e7d0-49ea-9d3c-555df9f58634 uuid:5D20892493BFDB11
Physical Therapy & Rehabilitation | Aurora Health Care 833-528-7672 Español Find a Doctor Find a Location Pay a Bill Sign in to LiveWell Appointments Patients & Visitors Services & Specialties Search SEARCH Menu Home Services & specialties Physical therapy & rehabilitation Services & specialties Physical therapy & rehabilitation Page navigation Physical therapy & rehabilitation Find a physical therapist Whether you’re recovering from an illness or injury or coping with a chronic condition, rehab or physical therapy can help. At Aurora Health Care, we offer both
ESS Tech, Inc. (Form: 10-K, Received: 03/05/2026 16:11:22) 00018194382025FYFalseP3Y0M0Dhttp://fasb.org/us-gaap/2025#ResearchAndDevelopmentExpense440.250.0625http://fasb.org/us-gaap/2025#CostOfRevenuehttp://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrent1iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesghw:hourxbrli:pureghw:trancheghw:paymentghw:productionLineghw:tradingDayghw:segment00018194382025-01-012025-12-310001819438us-gaap:CommonStockMember2025-01-012025-12-310001819438us-gaap:WarrantMember2025-01-012025-12-3100018194382025-06-3000018194382026-02-2700018194382025-12-3100018194382 … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule … . We have over 315 patents that are granted, applied for or in the pipeline for application, and an undisclosed number of trade secrets. Without taking into account any possible patent term adjustments or extensions, the earliest our current, issued patents will begin to expire in 2028. We continually review our efforts to assess the existence and patentability of new proprietary technology. We intend to leverage our iron flow expertise to drive innovation and are pursuing ad … business conditions and the availability of credit. The following risk factors apply to our business and operations. These risk factors are not exhaustive, and investors are encouraged to perform their own investigation with respect to our business, financial condition and prospects. We may face additional risks and uncertainties that are not presently known to us, or that we currently deem immaterial, which may also impair our business. The following discussion should be re … our recurring history of losses and an insufficient amount of cash available to fund our ongoing operations for the next year, we have concluded that there is a substantial doubt regarding our ability to continue as a going concern for a period of at least 12 months beyond the filing of this Annual Report on Form 10-K. Any such inability to conti
%PDF-1.4 %���� 18519 0 obj > endobj xref 18519 31 0000000016 00000 n 0000003907 00000 n 0000004092 00000 n 0000004130 00000 n 0000004566 00000 n 0000004760 00000 n 0000005510 00000 n 0000005624 00000 n 0000006145 00000 n 0000006867 00000 n 0000007599 00000 n 0000008255 00000 n 0000008909 00000 n 0000009236 00000 n 0000009755 00000 n 0000010359 00000 n 0000010475 00000 n 0000011156 00000 n 0000011547 00000 n 0000012137 00000 n 0000012796 00000 n 0000017329 00000 n 0000023395 00000 n 0000028491 00000 n 0000028599 00000 n 0000029305 00000 n 0000029603 00000 n 0000029933 00000 n 0000032201 00000 n … ,�/�[H�-����1:[�{3)��l�ךw��T�G����S�Ec����`�ﵯ�kl� > endobj 65 0 obj >stream application/pdf bluekuvio5_3 2012-08-09T14:18:22+03:00 2012-08-09T14:18:22+03:00 2012-06-13T13:27:44+03:00 Adobe Illustrator CS4 228 256 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK
DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f
Hx8fHx8fHx8fHx8 … 8D1D8EE26D53376B uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf converted from application/pdf to <unknown> saved xmp.iid:D27F11740720681191099C3B601C4548 2008-04-17T14:19:15+05:30 Adobe Illustrator CS4 / converted from application/pdf to <unknown> converted from application/pdf to <unknown> saved xmp.iid:F97F1174072068118D4ED246B3ADB1C6 2008-05-15T16:23:06-07:00 Adobe Illustrator CS4 / saved xmp.iid:FA7F1174072068118D4ED246B3ADB1C6 2008-05-15T17:10:45-07:0 … DDFD38D0CF24DD 2008-05-16T10:35:43-07:00 Adobe Illustrator CS4 / converted from application/pdf to <unknown> saved xmp.iid:F97F117407206811BDDDFD38D0CF24DD 2008-05-16T10:40:59-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to <unknown> saved xmp.iid:FA7F117407206811BDDDFD38D0CF24DD 2008-05-16T11:26:55-07:00 Adobe Illustrator CS4 / saved xmp.iid:FB7F117407206811BDDDFD38D0CF24DD 2008-05-16T11:29:01-07:00 Adobe Illustrator CS4 / saved … C1BF14D1759E83 2008-05-16T15:52:22-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator saved xmp.iid:FA7F117407206811B628E3BF27C8C41B 2008-05-22T13:28:01-07:00 Adobe Illustrator CS4 / converted from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator saved xmp.iid:
%PDF-1.4 %���� 2536 0 obj > endobj xref 2536 16 0000000016 00000 n 0000004788 00000 n 0000004890 00000 n 0000005023 00000 n 0000005476 00000 n 0000005587 00000 n 0000005716 00000 n 0000007679 00000 n 0000008063 00000 n 0000015980 00000 n 0000016237 00000 n 0000016366 00000 n 0000016431 00000 n 0000016799 00000 n 0000160044 00000 n 0000000616 00000 n trailer ]/Prev 6817633>> startxref 0 %%EOF 2551 0 obj >stream h��Zy\SW�>77� $@�Y5Ā"�� h; DDD@@��Bl�e*.�MXԸ* ZjC\f\�Ui��B�6��]>'Xm��3��Vf��{oH�=q�̿�?�;��9ϻ=�{�I���,� �/_� � xA�]�J5[��-���-��^ �'L�P� gc,��Hp!�y�d0S^`#O�`f� �{ … �3��ztƵ:��a��6�� �%n�H/ר9�1�|�Y{ce'}�Ʋ��/9f"\78�c�l�l�4�_uk�&�CY�E >7�RFp�Ƚ��ݪ��N �W9�&����j� �XD �Uhܒ��x������݅ `�L.o�H.��7�!G\��cȦ�5s#�n�r��P ��a�^�D Ɛ�Fic!h'zW�g�e=*{�T��F˪b-ݪ���� I�ߥ6�T �$B5: �U3 m��WԪ6�Ib��CMw���� ��R�,�);ƗS!뙖��Ҙ�GC�S0�0�~ �}3�$�5���kI�k? �]�)i�Ů�t�R�KA8��R�[�zƞ:����2���HH:�E���2�!կ}5��v2LT���� 3_�G:��5�ё���� ��� � U�>O �{�Ũ��j��� �G��x�5> ��\�l� �ܥ�`�"�� ���Hw AY�-r�Y��2� U�fH��֤�Y,N� �K´ѭoEV?'۸m�L�G�/�#�H>�4 … �*�(�(�Qc��"8��P�%[)[)Z�ZLE�(��$�=4d�j�GB8�!L�\�,Ы�I��Ɔ5��?�ЙիT��'��RfP��"8��>n�q*�6C�Xf��3c�"3"&ȒL̊ i��`�͏Z*K�I�2$A�� ��T92��Ej($Ɋ5�M$��fi"�y2�!�V�^���F�6Z�2�di X�. $�bR��8Պ R�Dh�h�m��#I6ȑ4N*���0 ŹVS�#4�c�IR8&�L� (�P�qT�b����c�E�$! i��Ԙ� ;�a-d�c-\���p�*D�Zf�fM�o]�1���n=��i'*�rh�5d�%(�A�d��f�Q�F%\s�e95 �*�(R��hՌ���~6Hř �s�#.L�FΚI)��RK����� ��1C�4"���C���$�R��Ut����4�)D���l�IIːc,c���y%D���-E�ɑ�D��b��n1c1k5{q2���V�5f�Ld��$fHdFFp�¶" … e&P���-×%dz�}���K)�y� dq�s�/[��=�.Qb��k}T�C��q���6�Y��8�٭3�a�-Ȩxo�q( =�_�rfP�%�mfh��n Ź���a���z�M�^ �^^o^VZW�[Avd�z�EN������#?���e0 I� _�T( �.S`��� ��g�I}G 1 �� HB���� _�������?����߆?|�� /����pKR��2G�� ���F�����zS�j�5gk�� K���դ{�%���@�I�KN���.�ٍ�*�n�{� ���F��TҨ� XI8�H4����갺���=�2��Vo�lh�\���i����#��CV ��3ی �+8)�}賅~�7������KR'�����W(�%^�� P���T�,֥�}���Gl_1� �t� N�"�{B��h�f�$1)��E�_�@\{ϒ��蒐q := c����Ц��Q��j9S�谓gȖ�so����&�\�@�yLX�p��%N�̅�Ē_��Ċ�3� … �������d6ز�`������Vi� � ���~A�0���6;�_�/(� Ŗخ��A�o%q��-ǭS����>j@N�d��G�wr�rFp��ШzE�핬�&�5ɷ��=Ԅ�A�UT�k�|]v�O��d��){-´�!� !�#8��p�c�hJ^A �#�Ad ��&�^H�:D�!��_i����,�o 7��b{��E��&>� g �4x���y{���!y�#g$x�+SÝ����1�- .�i:��UYv ���Jw/@=�Wc7����!c[����ZH�YS67NS�9e�LSxЖY x�F���j��/) ��ة����M1����Tk�'W��S��� ��8�$��c��(�C���/ �OV�
#dataliteracy #data #analytics #datadriven #careers #personalseveopment | Jordan Morrow | 27 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agre
%PDF-1.6 %���� 704 0 obj > endobj 714 0 obj >/Filter/FlateDecode/ID[ ]/Index[704 19]/Info 703 0 R/Length 65/Prev 1330771/Root 705 0 R/Size 723/Type/XRef/W[1 2 1]>>stream h�bbd``b���]@�� ��L�A�� $�����0�X!�����d100�&����`�� endstream endobj startxref 0 %%EOF 722 0 obj >stream h��WmL[�>�_\Sl�k�3��`w��3�9��f� 5 `g$j��s�c�C��n�(CS�F��H��N���Mj�i�I�6 4�-�&�d���g��6"U���i t��� ��{�y�������[PPl�/�A"�K�M���+°�%(�S�sm�"�$��w���7�vU�#vá� A`�]�{�h���aF���� +��? � '΄��k� �g����� 3��0=#~C�q��ׂ�Ut{ �����?!��w��'E�uF�'�� ��ҫժ���v�'���ž�Ώ�o�{�y�����ӻ��n��s\Y��=��U�U������ … p������a%��0.0I�4yg�\�n71�D\� �&rV���6{�K�NI� �X�K��t���C�|�f����� >stream application/pdf SocfinAsia-RA Natural Rubber 5 years+ 2026-03-17T17:04:16Z 2026-03-17T17:04:16Z 2026-03-17T17:04:15+01:00 Adobe Illustrator 29.8 (Windows) uuid:a80c0d30-b6a3-4ced-a90f-53f7f35157a6 xmp.did:9631027e-6d53-4c26-8ec5-9cd2d334593f uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:4989b332-3164-4078-a15b-2cd36f3706fc xmp.did:dfdceecc-2f37-954c-9a60-7b9f208cfc07 uuid:5D20892493BFDB1191 … LAB 50.588234 55 53 Adobe PDF library 17.00 endstream endobj 126 0 obj >stream application/pdf SocfinAsia-RA Natural Rubber 1 year+ 2026-03-17T16:56:21Z 2026-03-17T16:56:21Z 2026-03-17T16:56:20+01:00 Adobe Illustrator 29.8 (Windows) uuid:7d3c6901-6694-46fb-8a88-14cae7884f2c xmp.did:664aa264-6799-449c-94cf-451edbae97f5 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:23efc3c9-12f7-4601-9dde-0206fb912824 xmp.did:78c501e5-83de-8741-ac14-1c60b80c8c50 uuid:5D20892493BFDB11914 … s� �nf�ſ{%� ���P A1�+ej�)o� C?Fn�?#����-�Zl ]ه����O��z���o{�3� >stream application/pdf SocfinAsia-RA Palm Oil 5 years+ 2026-03-17T17:31:07Z 2026-03-17T17:31:07Z 2026-03-17T17:31:06+01:00 Adobe Illustrator 29.8 (Windows) uuid:7143af05-d24d-46d0-9af8-a320cff9c96f xmp.did:09b7282b-8b7b-4479-bf71-724ddf49ec4c uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:1b95320c-4995-4d4a-9cbf-61b03e9b04fb xmp.did:56c32758-8b6a-6446-b3d8-12637dd5cdc6 uuid:5D20892493BFDB11914A8590 … LAB 50.588234 55 53 Adobe PDF library 17.00 endstream endobj 135 0 obj >stream application/pdf SocfinAsia-RA Palm Oil 1 year+ 2026-03-17T17:22:19Z 2026-03-17T17:22:19Z 2026-03-17T17:22:18+01:00 Adobe Illustrator 29.8 (Windows) uuid:e1ddf2e4-14de-47dd-97da-f52d43d75e72 xmp.did:63b19ab3-5235-4217-b1be-9651a255e0a3 uuid:5D20892493BFDB11914A8590D315
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
%PDF-1.7 %���� 1364 0 obj > endobj xref 1364 41 0000000016 00000 n 0000005200 00000 n 0000005333 00000 n 0000005466 00000 n 0000006117 00000 n 0000006668 00000 n 0000006707 00000 n 0000006822 00000 n 0000007084 00000 n 0000008878 00000 n 0000010888 00000 n 0000012902 00000 n 0000014782 00000 n 0000015276 00000 n 0000015577 00000 n 0000017695 00000 n 0000018142 00000 n 0000018415 00000 n 0000020340 00000 n 0000022359 00000 n 0000023904 00000 n 0000413739 00000 n 0000430025 00000 n 0000436049 00000 n 0000450030 00000 n 0000473080 00000 n 0000484451 00000 n 0000496225 00000 n 0000513444 00000 n 0 … ��EF��q�rf� CįQ9ZY�$r!���6m �)�4� ��V�9�k�J�$#�� Fь�X��٥�C��p�[��ģ)C���S�;rFP#�I�m�K�G ɺ��z���j>>��X�9,�ZL-j��Ib�k��ȉ8�˚?v�t���� �x������P�IO}�_ay@ ��:����|Ve�6�����ubd/e�3 T� Sؓ�7X����?MM�!���Լu�O��t����P Cbt;���i����ް��a��@gW��#�@��4c�9.D���o� z2>M�5��i�~�u0� �q�s �wQ�9�ǸLt��삟�Mz)>���kɝ���I�;���io�"���U)��]$Y���L >� $����$T����:gUo$���UK���,�C�`sCMAJMÄ��K��C(��g]���ٮ9�s�U�G�0?����L�5��� �QM%��0O�l��5&���`�Ƒ 1,��x�'���{��k+�mY�}��� … :a950207c-bc4f-11b2-0a00-000000000000 uuid:177cdc44-adde-f543-a708-cf16d33bdb5e application/pdf Adobe PDF Library 17.0 endstream endobj 1354 0 obj > endobj xref 0 1364 0000000000 65535 f 0000637300 00000 n 0000637742 00000 n 0000640718 00000 n 0000644956 00000 n 0000645263 00000 n 0000656202 00000 n 0000662004 00000 n 0000662396 00000 n 0000663242 00000 n 0000675336 00000 n 0000676000 00000 n 0000677512 00000 n 0000678073 00000 n 0000678665 00000 n 0000678940 00000 n 00006790
%PDF-1.5 %���� 1 0 obj >stream application/pdf Working class|Statistics|Labor productivity Tables of Working Life: Length of Working Life for Men : Bulletin of the United States Bureau of Labor Statistics, No. 1001 Working class|Statistics|Labor productivity United States. Bureau of Labor Statistics ABBYY FineReader 12; modified using iTextSharp 4.1.6 by 1T3XT endstream endobj 2 0 obj >/ExtGState >/ProcSet[/PDF/ImageB]>>/CropBox[0 0.02 518.4 728.52]/Parent 7 0 R/Type/Page>> endobj 3 0 obj >stream H��w,*�LKL.Q����,HU�HLOU��srqV�*�25��3Q0Bs# =SK��H!9�K�3�@�%�+����T ٤�Ҥ�a�%�E��E� �3�K2��v
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ